October 31, 2025

MAGIC: AI-assisted laser tag illuminates cancer origins

MAGIC: AI-assisted laser tag illuminates cancer origins

EMBL researchers have developed a new AI tool, which, through a game of molecular laser tag, identifies cells that can shed light on the earliest origins of cancer

MAGIC operates like a fully automated game of laser tag, spotting cells with a particular visible feature, like the presence of micronuclei, and marking them using a system involving a laser and a photoconvertible dye. Credit: Daniela Velasco/EMBL

Summary

  • During cell division, chromosomal abnormalities – defects in chromosome number or structure – can occur, which can cause particularly aggressive forms of cancer.
  • A new study has shed light on how chromosomal abnormalities arise in normal cells, the rates at which they do so, and how these rates are affected by various factors.
  • To do this, the scientists developed a novel and versatile artificial intelligence (AI) tool called MAGIC, which combines automated microscopy and image analysis with single-cell genome sequencing.
  • Understanding the molecular origins of cancer in this way could pave the way for better genetic detection tools and potential medical prevention strategies in the future.

The human body relies on precise genetic instructions to function, and cancer begins when these instructions get scrambled. When cells accumulate genetic errors over time, they can break free of the normal controls on their growth and divide excessively. Chromosomal abnormalities – numerical and structural defects in chromosomes – are a common first step in this process, often contributing to normal cells turning cancerous. 

A new AI tool developed by researchers in the Korbel Group at EMBL Heidelberg now offers a powerful method to gain deep insights into how such chromosomal abnormalities arise in the first place. This knowledge could eventually help scientists understand the origin of cancer.

“Chromosomal abnormalities are a main driver for particularly aggressive cancers, and they’re highly linked to patient death, metastasis, recurrence, chemotherapy resistance, and fast tumour onset,” said Jan Korbel, senior scientist at EMBL and senior author of the new paper, published in the journal Nature. “We wanted to understand what determines the likelihood that cells undergo such chromosomal alterations, and what’s the rate at which such abnormalities arise when a still normal cell divides.”

The idea of chromosomal abnormalities leading to cancer is not new. In fact, more than a century ago, German scientist Theodor Boveri was the first to hypothesise, based on microscopy studies, that abnormal chromosomal contents in a cell contribute to the development of cancer. 

However, since only a small fraction of cells display chromosomal abnormalities at a given time, and these cells often die (or are killed off) via a natural selection process, their detection has previously proved to be a key challenge. Scientists had to manually spot such cells under the microscope, and only a handful of cells could be isolated at a time for further analysis. 

Marco Cosenza, Research Scientist in the Korbel Group, hit upon the solution to this problem after working with other teams at EMBL wrestling with similar challenges. He and his collaborators developed a new, autonomous system that combines automated microscopy, single-cell sequencing, and AI, which they named machine learning-assisted genomics and imaging convergence – or MAGIC. 

‘Laser tag’ to precisely identify and mark cells

Essentially, MAGIC operates like a fully automated game of laser tag. It spots ‘enemies’, or cells, with a particular kind of visible feature. For this study, the scientists focused on a cellular structure called a ‘micronucleus’. Micronuclei are tiny enclosed compartments inside cells that contain a small portion of the cells’ DNA, broken off from the bulk of the genome. Cells with micronuclei tend to produce new chromosomal abnormalities, which makes them more likely to turn cancerous. 

Once cells with micronuclei are detected, the system ‘tags’ them using a laser. For this, the scientists used a photoconvertible dye – a fluorescent molecule that undergoes a chemical transformation if light is shone on it, changing the colour of light it emits.  

“This project combined a lot of my interests in one,” said Cosenza. “It involves genomics, microscopic imaging, and robotic automation. During the COVID-19-related lockdown in 2020, I could really spend some time on learning and applying AI computer vision technologies to the biological image data we had collected before. Afterwards, we designed experiments to validate it and take it further.”

In practice, MAGIC works like this. First, an automated microscope captures a series of images of a cell sample. Next, a machine learning algorithm, trained on manually annotated datasets of micronuclei-containing cells, scans the images. When the algorithm spots cells with micronuclei, it shares their location with the microscope and instructs it to shine light specifically on those cells, permanently tagging them. The tagged cells can then easily be separated from these still-living cells using methods like flow cytometry, and subsequently be subjected to deeper analysis, e.g. by looking at their cellular genomes. 

You are currently viewing a placeholder content from YouTube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

More Information

By automating the previously labour-intensive, time-consuming, and error-prone process of detecting cells with micronuclei, MAGIC allows scientists to study such cells at a scale and speed previously unheard of. In less than a day, scientists can analyse nearly 100,000 cells using this method. 

The team used MAGIC to analyse chromosomal abnormalities in cultured cells originally derived from normal human cells. Their results showed that a little more than 10% of all cell divisions result in spontaneous chromosomal abnormalities of some kind and that this rate nearly doubles when a particular gene – p53, a well-known tumour suppressor – is mutated. The scientists also studied other triggers and contributors to chromosomal abnormality formation, such as the presence and location of double-stranded DNA breaks within a chromosome.

The study involved collaborations across and outside EMBL, with key contributions from the Advanced Light Microscopy Facility (ALMF) and the Pepperkok Team at EMBL Heidelberg, Isidro Cortes-Ciriano’s group at EMBL-EBI, and Andreas Kulozik’s team at the German Cancer Research Centre (DKFZ), which also forms part of the Molecular Medicine Partnership Unit (MMPU) between EMBL and the University of Heidelberg.

MAGIC is a highly versatile and adaptable technique. While the scientists trained it for this study to spot cells that had micronuclei, the algorithm can, in theory, be trained on many different kinds of datasets to detect different cellular features. 

“As long as you have a feature that can be discriminated visually from a ‘regular’ cell, you can – thanks to AI – train the system to detect it,” said Korbel, “Our system therefore has potential to advance future discoveries in numerous areas of biology.” 

Source article(s)

Origins of chromosome instability unveiled by coupled imaging and genomics

Cosenza M.R. et al

Nature 29 October 2025

10.1038/s41586-025-09632-5

Related links

Our latest News

discover more
Prof. Gudrun Rappold receives medal of honor from the German Society for Human Genetics

Prof. Gudrun Rappold receives medal of honor from the German Society for Human Genetics

Prof. Dr. Gudrun Rappold, senior professor at Heidelberg University’s Medical Faculty, has been awarded the Medal of Honor by the German Society for Human Genetics. The Medal of Honor is the highest award given by the professional association and recognizes outstanding scientific achievements in human genetics as well as special contributions to the advancement of […]

How cancer immunotherapies affect the heart

How cancer immunotherapies affect the heart

The Hector Foundation is providing €1.3 million in funding for an interdisciplinary research project investigating the cardiological side effects of checkpoint inhibitors. The consortium, with partners at Heidelberg University’s Medical Faculty, the German Cancer Research Center, the Max Delbrück Center in Berlin, and the University Medical Center Schleswig-Holstein in Kiel, is investigating why these cancer […]

Early detection contributes to declining breast cancer mortality rates in Europe

Early detection contributes to declining breast cancer mortality rates in Europe

The introduction of mammography screening programs in Europe has significantly changed breast cancer diagnoses, accompanied by a decline in breast cancer mortality rates. This is shown by one of the most comprehensive analyses of population-based data on breast cancer in 21 European countries to date, led by the German Cancer Research Center (DKFZ). The most […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp